EGFR and amyotrophic lateral sclerosis: Indeed, there is an increasing appreciation that ALS is a heterogenous disorder; further biomarker analysis of ALS populations may yield subsets of patients whose disease may be susceptible to pan-ERBB/HER inhibition.